Michael Benatar

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Alan E. Renton, Elisa Majounie, Adrian J. Waite et al. · Neuron · 2011 · 4.5K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Randomized Trial of Thymectomy in Myasthenia Gravis

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · New England Journal of Medicine · 2016 · 905 citations · Full text

Medicine, Endocrinology, Surgery +12

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion

Michael Benatar, Joanne Wuu, Peter M. Andersen et al. · Annals of Neurology · 2018 · 282 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis

Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski et al. · Science Translational Medicine · 2017 · 268 citations · Full text

Life Sciences, Neurology, Neuroscience +11